Literature DB >> 24798488

Bone-induced c-kit expression in prostate cancer: a driver of intraosseous tumor growth.

Leandro E Mainetti1, Xiaoning Zhe, Jonathan Diedrich, Allen D Saliganan, Won Jin Cho, Michael L Cher, Elisabeth Heath, Rafael Fridman, Hyeong-Reh Choi Kim, R Daniel Bonfil.   

Abstract

Loss of BRCA2 function stimulates prostate cancer (PCa) cell invasion and is associated with more aggressive and metastatic tumors in PCa patients. Concurrently, the receptor tyrosine kinase c-kit is highly expressed in skeletal metastases of PCa patients and induced in PCa cells placed into the bone microenvironment in experimental models. However, the precise requirement of c-kit for intraosseous growth of PCa and its relation to BRCA2 expression remain unexplored. Here, we show that c-kit expression promotes migration and invasion of PCa cells. Alongside, we found that c-kit expression in PCa cells parallels BRCA2 downregulation. Gene rescue experiments with human BRCA2 transgene in c-kit-transfected PCa cells resulted in reduction of c-kit protein expression and migration and invasion, suggesting a functional significance of BRCA2 downregulation by c-kit. The inverse association between c-kit and BRCA2 gene expressions in PCa cells was confirmed using laser capture microdissection in experimental intraosseous tumors and bone metastases of PCa patients. Inhibition of bone-induced c-kit expression in PCa cells transduced with lentiviral short hairpin RNA reduced intraosseous tumor incidence and growth. Overall, our results provide evidence of a novel pathway that links bone-induced c-kit expression in PCa cells to BRCA2 downregulation and supports bone metastasis.
© 2014 UICC.

Entities:  

Keywords:  BRCA2; bone metastasis; c-kit; invasion; prostate cancer

Mesh:

Substances:

Year:  2014        PMID: 24798488      PMCID: PMC4199873          DOI: 10.1002/ijc.28948

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  49 in total

1.  PDGF alpha-receptor signal strength controls an RTK rheostat that integrates phosphoinositol 3'-kinase and phospholipase Cgamma pathways during oligodendrocyte maturation.

Authors:  Randall D McKinnon; Sean Waldron; Mary E Kiel
Journal:  J Neurosci       Date:  2005-04-06       Impact factor: 6.167

Review 2.  Hypoxia, notch signalling, and prostate cancer.

Authors:  Laure Marignol; Karla Rivera-Figueroa; Thomas Lynch; Donal Hollywood
Journal:  Nat Rev Urol       Date:  2013-05-28       Impact factor: 14.432

3.  The role of microRNA genes in papillary thyroid carcinoma.

Authors:  Huiling He; Krystian Jazdzewski; Wei Li; Sandya Liyanarachchi; Rebecca Nagy; Stefano Volinia; George A Calin; Chang-Gong Liu; Kaarle Franssila; Saul Suster; Richard T Kloos; Carlo M Croce; Albert de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

4.  GATA2 and Sp1 positively regulate the c-kit promoter in mast cells.

Authors:  Keiko Maeda; Chiharu Nishiyama; Hideoki Ogawa; Ko Okumura
Journal:  J Immunol       Date:  2010-09-10       Impact factor: 5.422

5.  A c-fms tyrosine kinase inhibitor, Ki20227, suppresses osteoclast differentiation and osteolytic bone destruction in a bone metastasis model.

Authors:  Hiroaki Ohno; Kazuo Kubo; Hideko Murooka; Yoshiko Kobayashi; Tsuyoshi Nishitoba; Masabumi Shibuya; Toshiyuki Yoneda; Toshiyuki Isoe
Journal:  Mol Cancer Ther       Date:  2006-11       Impact factor: 6.261

Review 6.  Cancer susceptibility and the functions of BRCA1 and BRCA2.

Authors:  Ashok R Venkitaraman
Journal:  Cell       Date:  2002-01-25       Impact factor: 41.582

7.  MicroRNA-dependent regulation of cKit in cutaneous melanoma.

Authors:  O Igoucheva; V Alexeev
Journal:  Biochem Biophys Res Commun       Date:  2009-01-04       Impact factor: 3.575

8.  Phase I study investigating the safety and feasibility of combining imatinib mesylate (Gleevec) with sorafenib in patients with refractory castration-resistant prostate cancer.

Authors:  C Nabhan; D Villines; T V Valdez; K Tolzien; T M Lestingi; J D Bitran; S M Christner; M J Egorin; J H Beumer
Journal:  Br J Cancer       Date:  2012-07-17       Impact factor: 7.640

9.  The stem cell factor/c-kit receptor pathway enhances proliferation and invasion of pancreatic cancer cells.

Authors:  Akira Yasuda; Hirozumi Sawai; Hiroki Takahashi; Nobuo Ochi; Yoichi Matsuo; Hitoshi Funahashi; Mikinori Sato; Yuji Okada; Hiromitsu Takeyama; Tadao Manabe
Journal:  Mol Cancer       Date:  2006-10-18       Impact factor: 27.401

Review 10.  Putative role of HIF transcriptional activity in melanocytes and melanoma biology.

Authors:  Blazej Zbytek; Danielle L Peacock; Tiffany N Seagroves; Andrzej Slominski
Journal:  Dermatoendocrinol       Date:  2013-04-01
View more
  12 in total

1.  Investigation of c-KIT and Ki67 expression in normal, preneoplastic and neoplastic canine prostate.

Authors:  Carlos Eduardo Fonseca-Alves; Priscilla Emiko Kobayashi; Chiara Palmieri; Renée Laufer-Amorim
Journal:  BMC Vet Res       Date:  2017-12-06       Impact factor: 2.741

Review 2.  Prostate Cancer Stem Cell Markers Drive Progression, Therapeutic Resistance, and Bone Metastasis.

Authors:  Koran S Harris; Bethany A Kerr
Journal:  Stem Cells Int       Date:  2017-06-11       Impact factor: 5.443

Review 3.  CD117/c-kit in Cancer Stem Cell-Mediated Progression and Therapeutic Resistance.

Authors:  Brittni M Foster; Danish Zaidi; Tyler R Young; Mary E Mobley; Bethany A Kerr
Journal:  Biomedicines       Date:  2018-03-08

4.  In cancer cell lines inhibition of SCF/c-Kit pathway leads to radiosensitization only when SCF is strongly over-expressed.

Authors:  Fabian Eberle; Florian H Leinberger; Miriam F Saulich; Werner Seeger; Rita Engenhart-Cabillic; Jörg Hänze; Katja Hattar; Ekkehard Dikomey; Florentine S B Subtil
Journal:  Clin Transl Radiat Oncol       Date:  2017-02-28

Review 5.  Contributions of Thyroid Hormone to Cancer Metastasis.

Authors:  Shaker A Mousa; Gennadi V Glinsky; Hung-Yun Lin; Osnat Ashur-Fabian; Aleck Hercbergs; Kelly A Keating; Paul J Davis
Journal:  Biomedicines       Date:  2018-08-22

6.  CD117/c-kit defines a prostate CSC-like subpopulation driving progression and TKI resistance.

Authors:  Koran S Harris; Lihong Shi; Brittni M Foster; Mary E Mobley; Phyllis L Elliott; Conner J Song; Kounosuke Watabe; Carl D Langefeld; Bethany A Kerr
Journal:  Sci Rep       Date:  2021-01-14       Impact factor: 4.379

Review 7.  AKT in Bone Metastasis of Solid Tumors: A Comprehensive Review.

Authors:  Nico Hinz; Manfred Jücker
Journal:  Cancers (Basel)       Date:  2021-05-11       Impact factor: 6.639

8.  Gene expression analysis of bone metastasis and circulating tumor cells from metastatic castrate-resistant prostate cancer patients.

Authors:  Won Jin Cho; Daniel S M Oliveira; Abdo J Najy; Leandro E Mainetti; Hussein D Aoun; Michael L Cher; Elisabeth Heath; Hyeong-Reh C Kim; R Daniel Bonfil
Journal:  J Transl Med       Date:  2016-03-15       Impact factor: 5.531

Review 9.  RNAs as Candidate Diagnostic and Prognostic Markers of Prostate Cancer-From Cell Line Models to Liquid Biopsies.

Authors:  Marvin C J Lim; Anne-Marie Baird; John Aird; John Greene; Dhruv Kapoor; Steven G Gray; Ray McDermott; Stephen P Finn
Journal:  Diagnostics (Basel)       Date:  2018-08-30

10.  Integrated bioinformatics analysis reveals that the expression of cathepsin S is associated with lymph node metastasis and poor prognosis in papillary thyroid cancer.

Authors:  Juan Tan; Xiaoxiao Qian; Bin Song; Xiumin An; Tingting Cai; Zhihua Zuo; Dafa Ding; Yibing Lu; Hong Li
Journal:  Oncol Rep       Date:  2018-05-08       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.